Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OG5K
|
|||
| Former ID |
DAP001228
|
|||
| Drug Name |
Bismuth
|
|||
| Synonyms |
Bismut; Bismuto; Wismut; Bismuth standard for AAS; Bismuth standard for ICP; LTBB002773; Bismuth(III) nitrate solution; Bismuth, elemental; Bismuth-209; BISMUTH, 99.95%; BISMUTH, 99.999%; 83Bi
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Diarrhea [ICD-11: ME05.1; ICD-9: 787.91] | Approved | [1] | |
| Therapeutic Class |
Antidiarrheals
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
Bi
|
|||
| Canonical SMILES |
[Bi]
|
|||
| InChI |
1S/Bi
|
|||
| InChIKey |
JCXGWMGPZLAOME-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 7440-69-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:33301
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Serum albumin (ALB) | Target Info | Binder | [2] |
| Pathway Interaction Database | FOXA2 and FOXA3 transcription factor networks | |||
| Reactome | Platelet degranulation | |||
| Recycling of bile acids and salts | ||||
| HDL-mediated lipid transport | ||||
| Scavenging of heme from plasma | ||||
| WikiPathways | Human Complement System | |||
| Binding and Uptake of Ligands by Scavenger Receptors | ||||
| Lipid digestion, mobilization, and transport | ||||
| Transport of vitamins, nucleosides, and related molecules | ||||
| Bile acid and bile salt metabolism | ||||
| Folate Metabolism | ||||
| Vitamin B12 Metabolism | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds. Gastroenterology. 1991 Oct;101(4):889-94. | |||
| REF 2 | Competitive binding of bismuth to transferrin and albumin in aqueous solution and in blood plasma. J Biol Chem. 2001 Mar 23;276(12):8829-35. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.